4//SEC Filing
STEER RANDOLPH C 4
Accession 0000914190-21-000372
CIK 0000842023other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:26 PM ET
Size
22.3 KB
Accession
0000914190-21-000372
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
STEER RANDOLPH C
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-09-07−4,000→ 0 totalExercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2021-09-07$91.78/sh+4,000$367,120→ 13,112 total - Sale
Common Stock
2021-09-07$510.23/sh−4,600$2,347,052→ 5,612 total - Sale
Common Stock
2021-09-07$511.45/sh−500$255,725→ 5,112 total - Exercise/Conversion
Stock Option (right to buy)
2021-09-07−4,000→ 0 totalExercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - Sale
Common Stock
2021-09-07$509.33/sh−2,900$1,477,046→ 10,212 total - Exercise/Conversion
Common Stock
2021-09-07$87.39/sh+4,000$349,560→ 9,112 total
Holdings
- 3,985
Stock Option (right to buy)
Exercise: $101.19From: 2017-10-26Exp: 2026-10-26→ Common Stock (3,985 underlying) - 3,125
Stock Option (right to buy)
Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying) - 1,507
Stock Option (right to buy)
Exercise: $255.69From: 2021-10-28Exp: 2030-10-29→ Common Stock (1,507 underlying) - 1,898
Stock Option (right to buy)
Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Common Stock (1,898 underlying) - 4,260
Stock Option (right to buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 2,011
Stock Option (right to buy)
Exercise: $201.64From: 2020-10-24Exp: 2029-10-24→ Common Stock (2,011 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.978 to $509.769, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.98 to $510.597, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001198762
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:26 PM ET
- Size
- 22.3 KB